---
figid: PMC5685854__WJG-23-7478-g007
figtitle: Pathway of VEGFR-2 (produced using the Pathway Builder Tool)
organisms:
- NA
pmcid: PMC5685854
filename: WJG-23-7478-g007.jpg
figlink: /pmc/articles/PMC5685854/figure/F7/
number: F7
caption: 'Pathway of VEGFR-2 (produced using the Pathway Builder Tool). Bevacizumab
  targets VEGF-A to prevent its interaction with VEGFR-2; apatinib mainly targets
  VEGFR-2. VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial growth
  factor receptor.'
papertitle: 'Extraordinary response of metastatic pancreatic cancer to apatinib after
  failed chemotherapy: A case report and literature review.'
reftext: Cheng-Ming Li, et al. World J Gastroenterol. 2017 Nov 7;23(41):7478-7488.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9357203
figid_alias: PMC5685854__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5685854__F7
ndex: 667b23f1-df08-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5685854__WJG-23-7478-g007.html
  '@type': Dataset
  description: 'Pathway of VEGFR-2 (produced using the Pathway Builder Tool). Bevacizumab
    targets VEGF-A to prevent its interaction with VEGFR-2; apatinib mainly targets
    VEGFR-2. VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial
    growth factor receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFC
  - VEGFD
  - KDR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - PTK2
  - PXN
  - PXDN
  - MAPK3
  - MAPK1
  - ACDP
  - Apatinib
  - Cancer
---
